ZOË SCRIPTS
DEAD

Serial Number

85909662

Owner

RS Compounding, LLC

Attorney

Brittany J. Maxey

First Use Date

May 1, 2012

Filing Date

Apr 19, 2013

Add to watchlist:

No watchlists yet
View on USPTO

ZOË SCRIPTS Trademark

Serial Number: 85909662 • Registration: 4669519

ZOË SCRIPTS is a trademark filed by RS Compounding, LLC on April 19, 2013. The trademark is classified under Class 3 (Cosmetics & Cleaning), Class 5 (Pharmaceuticals), Class 40 (Treatment & Processing), Class 44 (Medical Services), Class 35 (Advertising & Business). The application is currently no longer active.

Owner Contact Info

RS Compounding, LLC

12617 Race Track Road
Tampa, FL 33626

Entity Type: 16

Trademark Details

Filing Date

April 19, 2013

Registration Date

January 13, 2015

First Use Anywhere

May 1, 2012

First Use in Commerce

May 1, 2012

Published for Opposition

October 28, 2014

Cancellation Date

August 20, 2021

Goods & Services

Custom manufacture of pharmaceuticals by pharmaceutical compounders

Chemical preparations for pharmaceutical or medical purposes, namely, for reducing pain, supporting and improving men's health in the nature of treating infertility, treating impotence, treating benign prostatic hyperplasia (BPH), treating parathyroid disease, reducing risk of kidney stones, reducing risk of prostate cancer, treating vitamin and mineral deficiencies, treating low testosterone levels, reducing risk of high cholesterol and hypertension, treating high cholesterol and hypertension, supporting and improving women's health in the nature of reducing symptoms and treating conditions associated with menopause, reducing symptoms and treating conditions associated with menstruation, treating ailments that occur during and after pregnancy, hormone replacement therapies to promote the health and wellbeing of the female reproductive system, maintenance of healthy urinary tracts, treating vitamin and mineral deficiencies, treating low estrogen, treating osteoporosis, reducing the risk of breast cancer, treating ophthalmic conditions and diseases, treating gastroesophageal reflux disease (GERD), treating dermatological conditions and diseases, treating thyroid dysfunction, and treating infections; Pharmaceutical preparations for the prevention and treatment of ophthalmic conditions and diseases, gastroesophageal reflux disease (GERD), dermatological conditions and diseases, thyroid dysfunction, and infections; Anti-infective preparations; Antiviral preparations; Antibiotic preparations; Antifungal preparations pharmaceutical preparations for skin care; Pain, anti-itch, anti-fungal and antibiotic ointments; Men's health ointments for use in treating infertility, treating impotence, treating benign prostatic hyperplasia (BPH), treating parathyroid disease, reducing risk of kidney stones, reducing risk of prostate cancer, treating vitamin and mineral deficiencies, treating low testosterone levels, reducing risk of high cholesterol and hypertension, treating high cholesterol and hypertension; Women's health ointments for use in reducing symptoms and treating conditions associated with menopause, reducing symptoms and treating conditions associated with menstruation, treating ailments that occur during and after pregnancy, hormone replacement therapies to promote the health and wellbeing of the female reproductive system, maintenance of healthy urinary tracts, treating vitamin and mineral deficiencies, treating low estrogen, treating osteoporosis, reducing the risk of breast cancer; Topical pain medications, gels, rubs and creams; Analgesic formulations by physician prescription; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals

Non-medicated ointments for the prevention and treatment of sunburn

Mail order pharmacy services

Pharmaceutical compounding services; Physician compounding services

Filing History

CANCELLED SEC. 8 (6-YR)
Aug 20, 2021 C8..
REGISTERED-PRINCIPAL REGISTER
Jan 13, 2015 R.PR
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Nov 6, 2014 TCCA
PUBLISHED FOR OPPOSITION
Oct 28, 2014 PUBO
UNDELIVERABLE MAIL - CORRESP. REMAILED
Oct 17, 2014 UNDR
NOTICE OF PUBLICATION
Oct 8, 2014 NPUB
LAW OFFICE PUBLICATION REVIEW COMPLETED
Sep 22, 2014 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 15, 2014 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 12, 2014 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 12, 2014 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Sep 12, 2014 ERFR
ACTION FOR REQ FOR RECON DENIED NO APPEAL FILED MAILED
Jun 13, 2014 RDX2
ACTION REQ FOR RECON DENIED NO APPEAL FILED COUNTED NOT MAILED
Jun 13, 2014 RRDX
TEAS/EMAIL CORRESPONDENCE ENTERED
May 27, 2014 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 27, 2014 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
May 27, 2014 ERFR
FINAL REFUSAL MAILED
Mar 20, 2014 CNFR
FINAL REFUSAL WRITTEN
Mar 20, 2014 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 11, 2014 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 11, 2014 CRFA
ASSIGNED TO LIE
Mar 3, 2014 ALIE
ASSIGNED TO LIE
Feb 28, 2014 ALIE
ASSIGNED TO LIE
Feb 19, 2014 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 13, 2014 TROA
NON-FINAL ACTION MAILED
Aug 13, 2013 CNRT
NON-FINAL ACTION WRITTEN
Aug 13, 2013 CNRT
ASSIGNED TO EXAMINER
Aug 6, 2013 DOCK
NOTICE OF DESIGN SEARCH CODE MAILED
Apr 27, 2013 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 26, 2013 NWOS